Technical Analysis for BLFS - BioLife Solutions, Inc.

Grade Last Price % Change Price Change
B 23.00 -0.86% -0.20
BLFS closed up 0.43 percent on Friday, June 2, 2023, on approximately normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up

Date Alert Name Type % Chg
Outside Day Range Expansion -0.86%
Wide Bands Range Expansion -0.86%
Overbought Stochastic Strength -0.86%
Wide Bands Range Expansion -0.43%
Overbought Stochastic Strength -0.43%
Wide Bands Range Expansion -1.50%
Overbought Stochastic Strength -1.50%
New Uptrend Bullish -1.54%
Wide Bands Range Expansion -1.54%
Overbought Stochastic Strength -1.54%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
10 DMA Support about 1 hour ago
Down 2 % about 1 hour ago
Reversed from Down about 2 hours ago
Gap Down Closed about 2 hours ago
Gap Down Partially Closed about 2 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

BioLife Solutions, Inc. Description

BioLife Solutions, Inc. (BioLife) is engaged in the developing, manufacturing and marketing hypothermic storage and cryopreservation solutions for cells and tissue. The Company’s product offerings include biopreservation media products for cells, tissues, and organs; generic formulations of blood stem cell freezing media products; custom product formulation and custom packaging services; precision thermal packaging products and C=contract aseptic manufacturing formulation, fill, and finish services of liquid media products. The Company markets it’s HypoThermosol, CryoStor, generic BloodStor, SAVSU biopreservation media products and precision thermal packaging products to the biobanking, drug discovery, and regenerative medicine markets, including hospital-based stem cell transplant centers, pharmaceutical companies, cord blood and adult stem cell banks, hair transplant centers, and suppliers of cells to the drug discovery, toxicology testing and diagnostic markets.


Classification

Sector: Healthcare
Industry: Medical Instruments & Supplies
Keywords: Biotechnology Life Sciences Pharmaceutical Biology Drug Discovery Stem Cell Cell Biology Regenerative Medicine Packaging Products Toxicology Organs Blood Adult Stem Cell Childbirth Cord Blood Media Products Organ Transplantation Packaging Services Toxicology Testing Cryopreservation

Is BLFS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 26.9576
52 Week Low 12.62
Average Volume 268,546
200-Day Moving Average 21.60
50-Day Moving Average 20.25
20-Day Moving Average 21.14
10-Day Moving Average 22.64
Average True Range 1.16
RSI (14) 67.21
ADX 28.93
+DI 30.19
-DI 12.21
Chandelier Exit (Long, 3 ATRs) 20.53
Chandelier Exit (Short, 3 ATRs) 19.75
Upper Bollinger Bands 24.70
Lower Bollinger Band 17.57
Percent B (%b) 0.79
BandWidth 33.69
MACD Line 1.02
MACD Signal Line 0.76
MACD Histogram 0.2537
Fundamentals Value
Market Cap 759.47 Million
Num Shares 32.7 Million
EPS 0.12
Price-to-Earnings (P/E) Ratio 196.61
Price-to-Sales 21.56
Price-to-Book 5.78
PEG Ratio 55.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 25.21
Resistance 3 (R3) 25.21 24.54 24.88
Resistance 2 (R2) 24.54 24.03 24.54 24.76
Resistance 1 (R1) 23.87 23.71 23.54 23.87 24.65
Pivot Point 23.20 23.20 23.03 23.20 23.20
Support 1 (S1) 22.53 22.69 22.20 22.53 21.75
Support 2 (S2) 21.86 22.37 21.86 21.64
Support 3 (S3) 21.19 21.86 21.53
Support 4 (S4) 21.19